Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

26 to 50 of 312 results

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

17-09-2014

The US Food and Drug Administration yesterday approved Movantik (naloxegol), an oral treatment for opioid-induced…

AstraZenecaGastro-intestinalsMovantikNektar TherapeuticsPharmaceuticalRegulationUSA

Lilly to pay up to $500 million for AstraZeneca Alzheimer’s candidate

Lilly to pay up to $500 million for AstraZeneca Alzheimer’s candidate

16-09-2014

Anglo-Swedish pharma major AstraZeneca and US peer Eli Lilly have entered an agreement to jointly develop…

AstraZenecaAZD3293Eli LillyLicensingNeurologicalPharmaceuticalResearchUKUSA

Redx Pharma and AstraZeneca collaborate on oncology research

04-09-2014

UK-based drug discovery firm Redx Pharma says it has entered into a research collaboration with Anglo-Swedish…

AstraZenecaOncologyPharmaceuticalRedx PharmaResearch

Cardiovascular disease has already cost six EU countries over $100 billion in 2014 alone

Cardiovascular disease has already cost six EU countries over $100 billion in 2014 alone

28-08-2014

Research by Anglo-Swedish drug major AstraZeneca into the cost burden of cardiovascular disease has shown…

AstraZenecaCardio-vascularEconomy of the European UnionEuropePharmaceuticalResearch

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

19-08-2014

Anglo-Swedish drug major AstraZeneca has received confirmation from the US Department of Justice that…

AstraZenecaBrilintaBrilintaCardio-vascularLegalPharmaceuticalUKUSA

AstraZeneca reports positive results from lesinurad trial for gout

AstraZeneca reports positive results from lesinurad trial for gout

13-08-2014

Anglo-Swedish drug major AstraZeneca has said its Phase III trials of lesinurad in combination with xanthine…

AstraZenecaEuropeGastro-intestinalslesinuradPharmaceuticalResearchSymptomatic gout

NICE comes back with different views on Tarceva and Iressa for NSCLC

NICE comes back with different views on Tarceva and Iressa for NSCLC

07-08-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) is consulting again…

AstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarcevaUK

AstraZeneca 2nd-qtr earnings leap, beating expectations

AstraZeneca 2nd-qtr earnings leap, beating expectations

31-07-2014

Anglo-Swedish pharma major AstraZeneca, which earlier this year defended itself against an unsolicited…

AstraZenecaBusiness FinanceFinancialPharmaceuticalUK

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

30-07-2014

Anglo-Swedish pharma major AstraZeneca today announced that it has entered into a clinical study collaboration…

AstraZenecaBriggs MorrisonImmunologyJapanKyowa Hakko KirinOncologyPharmaceuticalResearchUK

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

30-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement to gain rights to the respiratory franchise…

AlmirallAstraZenecaEkliraMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers

22-07-2014

UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

AstraZeneca reveals designs for new global R&D center and HQ in Cambridge, UK

AstraZeneca reveals designs for new global R&D center and HQ in Cambridge, UK

20-07-2014

Anglo-Swedish pharma major AstraZeneca on Friday revealed designs for its planned network of glass-walled…

AstraZenecaManagementPharmaceuticalResearchUK

AstraZeneca in research accord with Max Planck Institute

AstraZeneca in research accord with Max Planck Institute

08-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement with the Max Planck Institute of Molecular…

AstraZenecaCardio-vascularMetabolicsPharmaceuticalResearch

Negative view from FDA advisory for AstraZeneca’s olaparib

Negative view from FDA advisory for AstraZeneca’s olaparib

26-06-2014

There was disappointment for Anglo-Swedish pharma major AstraZeneca yesterday when a US Food and Drug…

AstraZenecaLynparzaolaparibOncologyPharmaceuticalRegulationUSA

ADDC and AstraZeneca partner to foster novel drug development among academic research community

ADDC and AstraZeneca partner to foster novel drug development among academic research community

17-06-2014

The Academic Drug Discovery Consortium has entered into a collaboration with Anglo-Swedish pharma major…

AstraZenecaPharmaceuticalResearch

Positive US FDA advisory panel view on PAMORAs

Positive US FDA advisory panel view on PAMORAs

13-06-2014

The majority of US Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee…

AstraZenecaGastro-intestinalsMovantiknaloxegolPharmaceuticalRegulationUSA

26 to 50 of 312 results

Back to top